These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14750462)

  • 1. Disease management and antikickback regulations.
    Kozma CM
    Manag Care Interface; 2003 Dec; 16(12):34-5. PubMed ID: 14750462
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceutical industry and payer partnerships: legal update.
    Goldstein WC
    Manag Care; 2001 Sep; 10(9 Suppl):5-6; discussion 9-12. PubMed ID: 11729439
    [No Abstract]   [Full Text] [Related]  

  • 3. Pharmaceutical company sponsored disease management programs: an alternative for tax-exempt MCOs and hospitals.
    Jedrey CM; Chaurette KA; Winn LB
    Manag Care Q; 2002; 10(3):11-5. PubMed ID: 12476660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Just what the doctor ordered: avoiding kickback pitfalls with prescription drugs.
    Simmer WS
    Manag Care Interface; 2002 Jan; 15(1):90-2. PubMed ID: 11828611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How well does your PBM perform?
    McCarthy R
    Bus Health; 1999 Jan; 17(1):24-9. PubMed ID: 10345211
    [No Abstract]   [Full Text] [Related]  

  • 6. Drug lawsuits building. Merck, Pfizer facing charges of misrepresentation.
    Benko LB
    Mod Healthc; 2006 Apr; 36(15):16. PubMed ID: 16669517
    [No Abstract]   [Full Text] [Related]  

  • 7. PBMs: ripe for regulation.
    Johnson RS
    Food Drug Law J; 2002; 57(2):323-69. PubMed ID: 12437004
    [No Abstract]   [Full Text] [Related]  

  • 8. The FDA's regulation of pharmaceutical communications in the context of managed care: a suggested approach.
    Kuhlik BN
    Food Drug Law J; 1995; 50(1):23-48. PubMed ID: 10342984
    [No Abstract]   [Full Text] [Related]  

  • 9. Avoid drug-marketing traps.
    Estabrook MA
    Manag Care; 2003 Feb; 12(2):48-9. PubMed ID: 12658859
    [No Abstract]   [Full Text] [Related]  

  • 10. Punishing health care fraud--is the GSK settlement sufficient?
    Outterson K
    N Engl J Med; 2012 Sep; 367(12):1082-5. PubMed ID: 22970920
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmaceutical company-sponsored disease management programs.
    Jedrey CM; Chaurette KA; Winn LB
    Manag Care Q; 2002; 10(1):56-60. PubMed ID: 15988959
    [No Abstract]   [Full Text] [Related]  

  • 12. Managed care gets a closer look from feds. Investigation pinpoints HMOs, free drug samples from pharmaceutical firms and Medicare fraud.
    Benko LB
    Mod Healthc; 2002 May; 32(21):10-1. PubMed ID: 12066388
    [No Abstract]   [Full Text] [Related]  

  • 13. Cooperative disease management programs.
    Jedrey CM; Chaurette KA; Winn LB
    J Ambul Care Manage; 2001 Jan; 24(1):15-25. PubMed ID: 11189793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

  • 15. The spotlight on PBMs: federal enforcement of the anti-kickback statute on the pharmaceutical benefit management industry.
    Radinsky G
    J Health Law; 2003; 36(2):213-46. PubMed ID: 12940677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doctor explains why he blew the whistle.
    Petersen M
    N Y Times Web; 2003 Mar; ():C1, C2. PubMed ID: 12812161
    [No Abstract]   [Full Text] [Related]  

  • 17. The response to health care reform by the pharmaceutical industry.
    Krulwich AS
    Food Drug Law J; 1995; 50(1):1-22. PubMed ID: 10342983
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical industry and payer partnerships to manage costs and improve quality.
    Mauch RP
    Manag Care; 2001 Sep; 10(9 Suppl):2-4; discussion 9-12. PubMed ID: 11729438
    [No Abstract]   [Full Text] [Related]  

  • 19. Disease state management: who should pay?
    Kozma CM
    Med Interface; 1997 Feb; 10(2):96-7. PubMed ID: 10164798
    [No Abstract]   [Full Text] [Related]  

  • 20. Implications for managed care organizations of the Merck and Medco consent.
    Pollard MR; Tilson HH
    Med Interface; 1996 Mar; 9(3):60-2. PubMed ID: 10184511
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.